Some research advocates fear the Advanced Research Projects Agency for Health could be left behind in a crush of end-of-session business and lose momentum.
Related posts:
Biden admin reveals plans for first 25 million donated vaccine doses
U.S. senators promise vaccines for Taiwan amid dispute with China
America’s pandemic stockpile struggles to ramp up
Biden admin preps for next pandemic as Delta variant surges
Leaders in under-vaccinated areas should ‘speak out’ amid virus surge, Fauci says
Fauci sees hope in new Merck drug
Labor turmoil rocks hospitals stretched by Delta
Democrats weigh vouchers for Medicare dental benefits amid funding squeeze
Democrats pitch industry-friendly Medicaid workaround to win Manchin’s support
FDA advisers endorse Covid-19 vaccine for kids 5-11 years old
States leapfrog feds on Covid boosters for all
Novavax asks FDA to authorize its Covid shot
